Physician variation in the de-adoption of ineffective statin and fibrate therapy.
Alexander EverhartNihar R DesaiBryan E DowdJeph HerrinLucas HigueraMolly Moore JefferyAnupam B JenaJoseph S RossNilay D ShahLaura Barrie SmithPinar Karaca-MandicPublished in: Health services research (2021)
On average, physicians decreased fibrate prescribing following the ACCORD lipid trial. However, many physicians increased prescribing following the trial. Observable physician characteristics did not explain variations in prescribing. Future research should examine whether physicians vary similarly in other de-adoption settings.